Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd., explained in plain language.
This study tested whether a new oral tablet (SHR2285) is as safe and effective as standard injections (enoxaparin) at preventing dangerous blood clots in the legs or lungs after knee replacement surgery. It involved 64 patients aged 40-75 who were scheduled for the operation. The…
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Mar 13, 2026 15:06 UTC